We are international
Donate
TEXT SIZE   
   back

IMF LOOKS FORWARD TO RAPID REVIEW OF REVLIMID FOR MYELOMA PATIENTS FOLLOWING FDA APPROVAL FOR MDS
12.28.05

Be the first to comment

 related articles